Bolt Biotherapeutics to Participate in Upcoming September Conferences
Provided By GlobeNewswire
Last update: Aug 28, 2024
REDWOOD CITY, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in September:
0.298
-0.03 (-7.97%)
Find more stocks in the Stock Screener
BOLT Latest News and Analysis
a day ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
